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BackgroundzzMutations in the spatacsin gene are associated with spastic paraplegia type 11 
(SPG11), which is the most-common cause of autosomal recessive hereditary spastic paraplegia. 
Although SPG11 has diverse phenotypes, thinning of the corpus callosum is an important feature.
Case ReportzzClinical, genetic, and radiological evaluations were undertaken in a large fami-
ly from Gujarat in North India with hereditary spastic paraplegia, whose affected members pre-
sented with varying degrees of spasticity, ataxia, and cognitive impairment. The clinical severity 
and the degree of corpus callosum and cerebellar atrophy varied among the four affected individ-
uals in the family. Genetic testing of the affected members revealed recessive mutations in the spa-
tacsin gene, consistent with a diagnosis of SPG11.
ConclusionszzWe believe that the extent of corpus callosum thinning and cerebellar atrophy 
is correlated with disease severity in affected patients. The addition of extrapyramidal features in 
the most-affected members suggests that SPG11 exhibits considerable phenotypic heterogeneity.
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Introduction
The hereditary spastic paraplegias are a clinically and geneti-
cally heterogeneous group of disorders. Recessive HSP tends 
to be complicated with additional features such as ataxia, 
neuropathy, seizures, and cognitive decline.
1 Recessive muta-
tions in the spatacsin gene underlie spastic paraplegia type 11 
(SPG11), the most-common type of recessive HSP in which 
affected individuals exhibit a thin corpus callosum (TCC) in 
addition to progressive spasticity, ataxia, neuropathy, seizures, 
cognitive decline, and abnormal eye signs.
2 We describe here-
in a large family originally from Gujarat in North India (Fig. 
1A) with progressive spastic paraplegia in whom we identi-
fied homozygous mutations in the spatacsin gene associated 
with SPG11. We report a relationship between disease severi-
ty in affected members, the addition of parkinsonian features 
in the most-severe case, and radiological correlation of the 
disease, in particular TCC and cerebellar atrophy.
Case Report
This family was referred to the HSP and rehabilitation clinic 
at The National Hospital for Neurology and Neurosurgery in 
London, UK. The family had come to London over 30 years 
ago and was originally from Gujarat in North India. After the 
establishment of consanguinity, it was noted that the four af-
fected family members had presented in adolescence with 
varying degrees of progressive spastic paraplegia and cogni-
tive impairment. Additional features included mild muscle 
wasting. The clinical features and the MRI findings were 
similar in each individual, but varied widely in severity (Fig. 
1B). In addition, the findings of nerve conduction studies and 
electromyography were normal in all four individuals.
Patient 1 was the proband and the most-severely affected 
member. Her motor milestones were delayed, and in particu-
lar her walking. She had developed progressive clumsiness, 
poor coordination, unsteadiness on her feet, and cognitive S Rajakulendran et al.
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impairment from the age of 8 years. She had always been 
poor at sports, and described difficulty walking and frequent 
falling over in her teenage years. Examination at the age of 
29 years demonstrated bilateral ptosis, significant cerebellar 
ataxia, and spastic dysarthria; she also had hypometric sac-
cades with broken pursuit movements; tone was raised in her 
upper limbs and profoundly increased in her lower limbs. In 
addition, she exhibited parkinsonian features with a stooped, 
festinant gait, a hypomimic face, bradykinesia, and cog-
wheeling in her upper limbs. She had a positive glabellar tap 
and limitation of upward gaze.
Patient 2 had milder symptoms. From the age of 10 years 
she had developed progressive gait difficulties, stiffness, and 
clumsiness. Examination at the age of 22 years revealed a 
spastic quadriparesis, spastic dysarthria, and cerebellar atax-
ia. She also exhibited limitation of upward gaze and skew 
deviation of the left eye. She had only mild cognitive impair-
ment.
Patients 3 and 4 are siblings, and cousins of patients 1 and 
2. Patient 3’s phenotype was almost identical to that of pa-
tient 2, while patient 4 was the least-affected member of the 
family, with symptom onset at the age of 15 years. Examina-
tion at the age of 18 years revealed normal upper limb tone, 
power, and reflexes. She exhibited only mild lower limb 
spasticity, but power was normal and her reflexes were not 
brisk. There was no evidence of cerebellar ataxia on exami-
nation. She exhibited no cognitive impairment.
Brain MRI demonstrated TCC and cerebellar atrophy (Fig. 
1B), which correlated with disease severity in the affected 
members. In addition, patient 1 had an increased signal in 
the basal ganglia on T2-weighted MRI, perhaps correspond-
ing to her parkinsonism. Analysis of spatacsin (KIAA1840)   
in all affected individuals identified a homozygous mutation, 
c.5769delT (Fig. 1C), which results in a truncated protein 
(p.Ser1923ArgfsX28), confirming the diagnosis of SPG11.
2,3
Discussion
The affected members of this family with SPG11 exhibited 
varying degrees of phenotypic severity and the development 
with age of additional features such as cerebellar ataxia and 
cognitive impairment. Although the absence of these find-
ings in all affected individuals is likely to be age related, oth-
er genes are also likely to influence the overall phenotype. 
Interestingly, patient 1 exhibited features of parkinsonism, 
which has only been described in the literature once before.
4 
This feature may be associated with more advanced disease, 
since few SPG11 cases have been assessed in their 30s. This 
is a potentially treatable manifestation that should be careful-
ly assessed in patients.
The extent of TCC and cerebellar atrophy was correlated 
with phenotypic severity in the affected members of this 
family. The most-striking findings were observed in patient 1, 
who exhibited the most-severe phenotype, and the least atro-
phy was seen in patient 4, who had the mildest phenotype. 
The phenotypes of patients 2 and 3 were of intermediate se-
verity. TCC is an important diagnostic feature in patients 
with autosomal recessive HSP, and seems to be correlated 
with disease severity. However, our observations are based 
on one family, and therefore need to be replicated in further 
Fig. 1. A: Family tree showing the four affected family members. 
B: Sagittal T2-weighted brain MRI scans demonstrating a correla-
tion between progressive thinning of the corpus callosum (white 
arrow) with cerebellar atrophy and disease severity in patient 4 
(mildly affected), patient 2 (moderately affected), and patient 1 (se-
verely affected). N: normal corpus callosum. C: Chromatogram of 
the spatacsin mutation identified. Arrow indicates the mutation po-
sition.
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affected families with patients of different ages and mutation 
types. Spatacsin pathogenic mutations have recently been 
identified in autosomal recessive juvenile amyotrophic later-
al sclerosis, in the absence of cognitive impairment and 
TCC,
5 suggesting that the clinical spectrum seen in spatacsin 
-associated disease is much wider than previously thought.
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